Natural killer (NK) cells are innate lymphocytes that provide critical host defense against
pathogens and cancer. Originally heralded for their early and rapid effector activity, NK cells …

The IL-1 family of cytokines currently comprises of seven ligands with pro-inflammatory
activity (IL-1α and IL-1β, IL-18, IL-33, IL-36α, IL-36β, IL-36γ) as well as two ligands with anti …

Treatment of cancer with allogeneic natural killer (NK) cell therapies has seen rapid
development, especially use against hematologic malignancies. Clinical trials of NK cell …

Despite the impressive results of autologous CAR-T cell therapy in refractory B
lymphoproliferative diseases, CAR-NK immunotherapy emerges as a safer, faster, and cost …

A variety of therapies have been developed and used for the treatment of colon cancer,
however, the high mortality rate remains high and more effective strategies are still in urgent …

The IL-1 family of cytokines consists of IL-1α, IL-1β, IL-18, IL-33, IL-36α, IL-36β, and IL-36γ.
These proteins form four signaling receptor complexes: the IL-1 receptor (IL-1R1 and IL …

Simple Summary A cancer treatment approach known as immunotherapy has become
popular in the medical field. In this case, immune cells are boosted for effective response …

Simple Summary B7-H3 costimulatory ligand has sparked tremendous interest as a target
for antibody-directed therapy of solid tumors. This is attributed to high expression of B7-H3 …

Natural killer (NK) cells are lymphocytes with a key role in the defense against viral
infections and tumor cells. Although NK cells are classified as innate lymphoid cells (ILCs) …

Background Stimulating antitumor immunity by blocking programmed death-1 (PD-1) or its
ligand (programmed death-ligand 1 (PD-L1) is a promising antitumor therapy. However …